作者更正：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和蝙蝠RaTG13刺突糖蛋白结构揭示病毒进化及弗林蛋白酶切割效应
Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
作者信息
Wrobel Antoni G, Benton Donald J, Xu Pengqi, Roustan Chloë, Martin Stephen R, Rosenthal Peter B, Skehel John J, Gamblin Steven J
机构信息
Structural Biology of Disease Processes Laboratory, Francis Crick Institute, London, UK.
Precision Medicine Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
出版信息
Nat Struct Mol Biol. 2020 Oct;27(10):1001. doi: 10.1038/s41594-020-0509-2.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
本文的一个修订版本已发表，可通过本文顶部的链接获取。
相似文献
1
Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.作者更正：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和蝙蝠RaTG13刺突糖蛋白结构揭示病毒进化及弗林蛋白酶切割效应
Nat Struct Mol Biol. 2020 Oct;27(10):1001. doi: 10.1038/s41594-020-0509-2.
2
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.弗林蛋白酶抑制剂可阻断 SARS-CoV-2 刺突蛋白裂解，抑制病毒产生和细胞病变效应。
Cell Rep. 2020 Oct 13;33(2):108254. doi: 10.1016/j.celrep.2020.108254. Epub 2020 Sep 23.
3
Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming.冠状病毒刺突糖蛋白引发的潜在治疗靶点
Molecules. 2020 May 22;25(10):2424. doi: 10.3390/molecules25102424.
4
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.新型冠状病毒 2019-nCoV 的刺突糖蛋白含有弗林蛋白酶样裂解位点，而同一进化枝的 CoV 中则没有。
Antiviral Res. 2020 Apr;176:104742. doi: 10.1016/j.antiviral.2020.104742. Epub 2020 Feb 10.
5
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.作者更正：猫冠状病毒药物可抑制SARS-CoV-2的主要蛋白酶并阻断病毒复制。
Nat Commun. 2020 Oct 20;11(1):5409. doi: 10.1038/s41467-020-19339-y.
6
Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.作者更正：一组类似SARS的循环蝙蝠冠状病毒显示出出现人间传播的可能性。
Nat Med. 2020 Jul;26(7):1146. doi: 10.1038/s41591-020-0924-2.
7
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.作者更正：中和纳米抗体结合严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突受体结合域（RBD）并阻断其与血管紧张素转换酶2（ACE2）的相互作用。
Nat Struct Mol Biol. 2020 Nov;27(11):1094. doi: 10.1038/s41594-020-00527-9.
8
The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.SARS-CoV-2 和其他人类冠状病毒的刺突蛋白针对人类气道的温度和蛋白酶进行了微调。
PLoS Pathog. 2021 Apr 22;17(4):e1009500. doi: 10.1371/journal.ppat.1009500. eCollection 2021 Apr.
9
Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.作者更正：COVID-19疾病图谱，构建SARS-CoV-2病毒-宿主相互作用机制的计算知识库。
Sci Data. 2020 Jul 17;7(1):247. doi: 10.1038/s41597-020-00589-w.
10
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.源自马蹄蝠 ACE2 直系同源物的突变增强了 ACE2-Fc 对 SARS-CoV-2 的中和作用。
PLoS Pathog. 2021 Apr 9;17(4):e1009501. doi: 10.1371/journal.ppat.1009501. eCollection 2021 Apr.
引用本文的文献
1
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses.高活性的 ACE2 诱饵亲和力成熟体对奥密克戎 SARS-CoV-2 和新出现的冠状病毒的抑制作用。
PLoS One. 2022 Aug 25;17(8):e0271359. doi: 10.1371/journal.pone.0271359. eCollection 2022.
2
Personal observations on COVID-19 and the conduct and application of biomedical science.关于COVID-19以及生物医学科学的开展与应用的个人观察
Interface Focus. 2021 Oct 12;11(6):20210053. doi: 10.1098/rsfs.2021.0053. eCollection 2021 Dec 6.
3
Phosphatidylserine receptors enhance SARS-CoV-2 infection.磷脂酰丝氨酸受体增强 SARS-CoV-2 感染。
PLoS Pathog. 2021 Nov 19;17(11):e1009743. doi: 10.1371/journal.ppat.1009743. eCollection 2021 Nov.
4
The zoonotic and natural foci characteristics of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的人畜共患病及自然疫源地特征
J Biosaf Biosecur. 2021 Jun;3(1):51-55. doi: 10.1016/j.jobb.2021.06.002. Epub 2021 Jun 24.
5
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.mRNA新冠疫苗MRT5500在临床前动物模型中的免疫原性和疗效
NPJ Vaccines. 2021 Apr 19;6(1):61. doi: 10.1038/s41541-021-00324-5.
Zotero 插件